OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inhibition of receptor‐binding domain—ACE2 interaction after two doses of Sinovac's CoronaVac or AstraZeneca/Oxford's AZD1222 SARS‐CoV‐2 vaccines
Valéria Oliveira Silva, Rosemeire Yamashiro, Cintia Mayumi Ahagon, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 3, pp. 1217-1223
Open Access | Times Cited: 12
Valéria Oliveira Silva, Rosemeire Yamashiro, Cintia Mayumi Ahagon, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 3, pp. 1217-1223
Open Access | Times Cited: 12
Showing 12 citing articles:
Application of Traditional Vaccine Development Strategies to SARS-CoV-2
Halie M. Rando, Ronan Lordan, Alexandra Lee, et al.
mSystems (2023) Vol. 8, Iss. 2
Open Access | Times Cited: 14
Halie M. Rando, Ronan Lordan, Alexandra Lee, et al.
mSystems (2023) Vol. 8, Iss. 2
Open Access | Times Cited: 14
An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines
Suhaila A. Al-Sheboul, Brent Brown, Yasemin Shboul, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 51-51
Open Access | Times Cited: 18
Suhaila A. Al-Sheboul, Brent Brown, Yasemin Shboul, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 51-51
Open Access | Times Cited: 18
Assessment of an in-house IgG ELISA targeting SARS-CoV-2 RBD: Applications in infected and vaccinated individuals
Hernan Hermes Monteiro da Costa, Valéria Oliveira Silva, Gustavo Carvalho Amorim, et al.
Journal of Immunological Methods (2024) Vol. 530, pp. 113683-113683
Closed Access | Times Cited: 2
Hernan Hermes Monteiro da Costa, Valéria Oliveira Silva, Gustavo Carvalho Amorim, et al.
Journal of Immunological Methods (2024) Vol. 530, pp. 113683-113683
Closed Access | Times Cited: 2
An unexpected IgE anti-receptor binding domain response following natural infection and different types of SARS-CoV-2 vaccines
Amanda Izeli Portilho, Valéria Oliveira Silva, Hernan Hermes Monteiro da Costa, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Amanda Izeli Portilho, Valéria Oliveira Silva, Hernan Hermes Monteiro da Costa, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Role of available COVID-19 vaccines in reducing deaths and perspective for next generation vaccines and therapies to counter emerging viral variants: an update
Mohd Wahid, Arshad Jawed, Raju K. Mandal, et al.
Minerva Medica (2023) Vol. 114, Iss. 5
Closed Access | Times Cited: 7
Mohd Wahid, Arshad Jawed, Raju K. Mandal, et al.
Minerva Medica (2023) Vol. 114, Iss. 5
Closed Access | Times Cited: 7
Centro de Imunologia do Instituto Adolfo Lutz ao longo dos anos
Raquel dos Anjos Fazioli, Márcia Jorge Castejón, Cyro Alves de Brito, et al.
BEPA Boletim Epidemiológico Paulista (2024) Vol. 21, pp. e40444-e40444
Closed Access | Times Cited: 1
Raquel dos Anjos Fazioli, Márcia Jorge Castejón, Cyro Alves de Brito, et al.
BEPA Boletim Epidemiológico Paulista (2024) Vol. 21, pp. e40444-e40444
Closed Access | Times Cited: 1
Evaluation of long-term antibody kinetics in healthcare workers vaccinated with inactivated COVID-19 Vero cell vaccine (CoronaVac), a propensity score-matched observational study
Yeşim Yıldız, Hasan Selçuk Özger, Esin Şenol, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 99-106
Open Access | Times Cited: 4
Yeşim Yıldız, Hasan Selçuk Özger, Esin Şenol, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 99-106
Open Access | Times Cited: 4
An unexpected IgE anti-Receptor binding domain response following natural infection and different types of SARS-CoV-2 vaccines
Amanda Izeli Portilho, Valéria de Oliveira Silva, Hernan Hermes Monteiro da Costa, et al.
Research Square (Research Square) (2024)
Closed Access
Amanda Izeli Portilho, Valéria de Oliveira Silva, Hernan Hermes Monteiro da Costa, et al.
Research Square (Research Square) (2024)
Closed Access
Impact of COVID-19 Vaccination on Mortality and Clinical Outcomes in Hemodialysis Patients
Rihong Hu, Jiazhen Yin, Tingfei He, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 799-799
Open Access
Rihong Hu, Jiazhen Yin, Tingfei He, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 799-799
Open Access
An Analysis of Severe Acure Respiratory Syndrome Coronavirus-2 (Sasrs-COV-2) Antibody Levels Determinant of Society in Gowa Regency
Syarifah Adriana, Ridwan Amiruddin, A. Zulkifli Abullah, et al.
International Journal of Chemical and Biochemical Sciences (2024) Vol. 25, Iss. 19
Open Access
Syarifah Adriana, Ridwan Amiruddin, A. Zulkifli Abullah, et al.
International Journal of Chemical and Biochemical Sciences (2024) Vol. 25, Iss. 19
Open Access
Comparison of antibody responses following natural infection with Severe Acute Respiratory Syndrome Coronavirus 2 or receipt of CoronaVac or ChAdOx1 (AZD1222) vaccination in Chiang Mai, Thailand
Sayamon Hongjaisee, Kriangkrai Chawansuntati, Patumrat Sripan, et al.
Vaccine X (2023) Vol. 14, pp. 100305-100305
Open Access | Times Cited: 1
Sayamon Hongjaisee, Kriangkrai Chawansuntati, Patumrat Sripan, et al.
Vaccine X (2023) Vol. 14, pp. 100305-100305
Open Access | Times Cited: 1
